Phase 1 Overweight or obese Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
Overweight or Obese AdultsOverweight or Obese, Type 2 Diabetes
Alveus Therapeutics, Inc.180 enrolled1 locationNCT07399678
Recruiting
Phase 1
A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects
HealthyNon-diabetic Overweight or Obese
BrightGene Bio-Medical Technology Co., Ltd.75 enrolled1 locationNCT07239973
Recruiting
Phase 1
Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects
Non-diabetic Overweight or Obese
BrightGene Bio-Medical Technology Co., Ltd.80 enrolled1 locationNCT07166081
Recruiting
Phase 1
A Study to Evaluate MWN109 Injection in Healthy Subjects
Overweight or obese
Shanghai Minwei Biotechnology Co., Ltd72 enrolled1 locationNCT06859853